Analyst IMS Investment Management Services’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-11,075
Closed -$1.02M 97
2019
Q2
$1.02M Sell
11,075
-450
-4% -$42.7K 0.31% 54
2019
Q1
$1.09M Sell
11,525
-2,020
-15% -$177K 0.33% 51
2018
Q4
$868 Sell
13,545
-901
-6% -$66.5K 0.14% 56
2018
Q3
$1.28K Sell
14,446
-1,433
-9% -$127K 0.2% 47
2018
Q2
$1.22M Buy
15,879
+4,770
+43% +$396K 0.37% 47
2018
Q1
$991K Buy
11,109
+992
+10% +$95.2K 0.31% 60
2017
Q4
$1.05M Buy
10,117
+3,171
+46% +$358K 0.32% 63
2017
Q3
$991K Sell
6,946
-190
-3% -$25.9K 0.33% 63
2017
Q2
$927K Sell
7,136
-80
-1% -$9.8K 0.33% 62
2017
Q1
$896K Sell
7,216
-370
-5% -$44.3K 0.35% 64
2016
Q4
$878K Sell
7,586
-89
-1% -$9.91K 0.38% 59
2016
Q3
$803K Sell
7,675
-290
-4% -$31.4K 0.34% 59
2016
Q2
$785K Sell
7,965
-90
-1% -$9.31K 0.33% 57
2016
Q1
$807K Buy
8,055
+1,120
+16% +$115K 0.35% 58
2015
Q4
$830K Sell
6,935
-570
-8% -$65.9K 0.35% 60
2015
Q3
$812K Buy
7,505
+1,305
+21% +$162K 0.34% 60
2015
Q2
$718K Buy
+6,200
New +$709K 0.28% 63

Other funds holding CELG

Analyst IMS Investment Management Services's CELG Position: Q3 2019 in Review

Analyst IMS Investment Management Services sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 11,075 shares — an estimated $1.02M sold.

Analyst IMS Investment Management Services first reported a position in CELG in Q2 2015 and held it in 17 quarters. The position peaked at $1.22M in Q2 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Analyst IMS Investment Management Services reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Analyst IMS Investment Management Services sold 11,075 Celgene Corp shares in Q3 2019, an estimated $1.02M.
  • Analyst IMS Investment Management Services first reported a position in Celgene Corp in Q2 2015 and held it in 17 quarters.
  • Analyst IMS Investment Management Services's Celgene Corp position peaked at $1.22M in Q2 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Analyst IMS Investment Management Services's 13F filing for Q3 2019, filed 12 Nov 2019.